PriceTracker GLP-1
Loading the index…

Try

Ozempic teeth: can semaglutide or tirzepatide damage your teeth?

No GLP-1 label lists tooth damage as a side effect, and no prospective study has measured teeth in people taking one. What dentists describe as Ozempic teeth runs through side effects the labels do list: vomiting and reflux that bathe teeth in stomach acid, and dry mouth, which raises the risk of decay. A 2026 dental review calls that risk plausible but unquantified. Rinsing after vomiting, fluoride and water are the ADA's answers.

8 min read · published October 2026

Studio still life: a glass of water, a plain white plate and a folded napkin

Key takeaways

  • 1No label for Ozempic, Wegovy or Zepbound lists tooth damage, and an October 2026 Journal of Dental Research review says no prospective study has used any dental outcome as an endpoint in people on a GLP-1.
  • 2The plausible routes are indirect: vomiting and reflux (both on the labels) put stomach acid on enamel, and dry mouth removes saliva's protection against decay.
  • 3How often: on Wegovy in weight-loss trials, 25% of people reported vomiting vs 6% on placebo; on Zepbound, 1% reported dry mouth or dry throat vs 0.1% on placebo. Most stomach side effects happened while the dose was being raised.
  • 4ADA advice for acid: after vomiting, rinse with water, a baking soda (sodium bicarbonate) rinse or milk rather than brushing straight away; brush with a soft brush and fluoride toothpaste.
  • 5For dry mouth, NIDCR suggests plenty of water, sugarless gum, and cutting caffeine, alcohol and tobacco. Tell your dentist you take a GLP-1.

No prescribing label for Ozempic, Wegovy or Zepbound lists tooth damage as a side effect, and no trial has measured it. An October 2026 review in the Journal of Dental Research put it bluntly: "no prospective study has used any dental outcome as an endpoint in patients receiving GLP-1RAs."1 What people call "Ozempic teeth" is damage that dentists trace to side effects the labels do list: vomiting and acid reflux, which put stomach acid on enamel, and dry mouth, which takes away saliva's protection. The same review calls that a "plausible but unquantified risk for tooth erosion and secondary caries".1

So the honest answer has two halves. The drug is not known to attack teeth directly; a second 2026 review says "a direct association with these therapies has not been established."2 But if you are vomiting often, living with reflux, or your mouth feels dry, your teeth are exposed to the same things that damage them in anyone, and the American Dental Association has specific advice for each.

What the labels list that can reach your teeth

None of the labels mention teeth, enamel or cavities. They do list the stomach side effects in detail, and those are where the dental worry starts. All three also say most of these happen while the dose is still being raised.

MedicineStomach side effects in trialsReflux and dry mouthWhen
Ozempic (semaglutide, type 2 diabetes)Any stomach side effect: 32.7% at 0.5 mg and 36.4% at 1 mg vs 15.3% on placebo3Gastroesophageal reflux disease: 1.9% and 1.5% vs 0% on placebo3"The majority of reports of nausea, vomiting, and/or diarrhea occurred during dose escalation"3
Wegovy (semaglutide 2.4 mg, weight loss)73% vs 47% on placebo; vomiting 25% vs 6%, nausea 44% vs 16%4Reflux disease listed among reactions more common than on placebo4"Most frequently reported during dosage escalation"4
Zepbound (tirzepatide, weight loss)56% at every dose vs 30% on placebo5Dry mouth or dry throat: 1% vs 0.1% on placebo5Mostly "during dose escalation and decreased over time"5

Mounjaro shares Zepbound's molecule and Rybelsus, the Ozempic tablets and the Wegovy pill share Ozempic's, so the same routes apply. Compounded semaglutide and tirzepatide have no FDA label of their own; they are the same molecules.

Three ways a GLP-1 can end up hurting teeth

1. Stomach acid from vomiting and reflux

Enamel dissolves in acid. The ADA describes dental erosion as "progressive, irreversible loss of tooth mineral substance" that "may be caused by intrinsic (e.g., acid reflux and excessive vomiting)" factors, and says reflux disease "is considered a predisposing factor for dental erosion due to chronic regurgitation of gastric contents."6 One bout of nausea in week two is not that. Weeks of frequent vomiting, or reflux that keeps coming back, can be. A 2026 oral medicine review says "gastric acid exposure from reflux or vomiting may increase susceptibility to dental erosion".2

2. Dry mouth

Saliva washes teeth and neutralizes acid. The NIH's dental institute says "dry mouth also increases the risk for tooth decay or fungal infections in the mouth because saliva helps keep harmful germs in check."9 The ADA's own list of medicines that "can contribute to or exacerbate oral dryness" now names "glucagon-like peptide-1 (GLP-1) receptor agonists" alongside antihistamines and antidepressants, and says reduced saliva can "increase the chance of developing dental caries, demineralization of teeth, tooth sensitivity, and/or oral infections."8

The signal for dry mouth is real but thin. Zepbound's label puts it at 1% of patients.5 For semaglutide, a 2023 case series described 3 patients who developed it, all of whom "resumed acceptable salivary flow" after treatment that ranged from stopping the drug to symptom care,10 and an analysis of FDA adverse event reports showed significant signals for semaglutide "in anosmia, dry mouth, dysgeusia".11 Adverse event reports show a pattern worth watching; they cannot tell you how often it happens.

3. Eating, drinking and dehydration

Less appetite often means less water too. The Ozempic Medication Guide warns that "diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration)" and says "it is important for you to drink fluids to help reduce your chance of dehydration."3 The 2026 oral medicine review lists "dehydration secondary to gastrointestinal adverse events" as one of the proposed reasons for dry mouth on these drugs.2 Sipping sugary or acidic drinks all day to get calories in adds to the acid load the ADA warns about.7

What the evidence shows, and what it does not

SourceWhat it isWhat it showed
J Dent Res, October 20261Critical review across dental fieldsErosion and decay risk "plausible but unquantified"; no prospective study with a dental endpoint
J Oral Pathol Med, October 20262Review of case reports and adverse event dataDry mouth, low saliva, taste change and mouth burning reported; a direct link to erosion "has not been established"; evidence "limited and largely indirect"
Medicine, 202310Case series, 3 patients on semaglutideLow saliva diagnosed in all three; saliva flow recovered
Laryngoscope, 202511FDA adverse event reports, five GLP-1 drugsReflux signal in every drug; semaglutide signals for dry mouth and taste change
Diabetes Res Clin Pract, 202612Health-record cohort, 97,993 matched patients per group, type 2 diabetesTirzepatide users had fewer recorded tooth extractions (HR 0.89) and less periodontitis (HR 0.70) than other GLP-1 users; needs prospective confirmation

Two things stand out. First, no study has followed people starting a GLP-1 and checked their teeth, so nobody can give you an honest percentage for "Ozempic teeth". Second, the gum research points the other way: the 2026 dental review says "preclinical evidence consistently demonstrates anti-inflammatory and osteoprotective effects on periodontal and peri-implant tissues",1 though preclinical work is not proof in people. The large 2026 cohort compared tirzepatide with other GLP-1s, not with no drug, and its authors say the associations "require confirmation in prospective studies with systematic dental assessments."12

How to protect your teeth while taking one

These steps are what the ADA and NIDCR advise for acid and dry mouth in general; they are not specific to GLP-1s, because no GLP-1-specific dental guidance exists yet.

ProblemWhat the source advises
After vomiting"Rinse the mouth with water, a sodium bicarbonate rinse, or milk"; the ADA cautions against "brushing their teeth immediately after vomiting"7
After acidic drinks"Rinse with water rather than brushing teeth immediately"7
Daily brushing"A soft-bristle brush and fluoride toothpaste"7
Dry mouthWater ("8 to 12 cups per day"), sugarless gum, and avoiding tobacco and alcohol9; sugar-free gum also helps saliva buffer acid7
Dry mouth that does not settleThe doctor or dentist may suggest "changing medications or adjusting the dosages, or may prescribe a saliva substitute"9
Vomiting or stomach problems that persistZepbound's Medication Guide: "Tell your healthcare provider if you have stomach problems that are severe or will not go away"5

Tell your dentist you take a GLP-1 and how long you have been on it. The 2026 oral medicine review asks clinicians for "careful medication history-taking, assessment of salivary function, and individualized preventive care",2 and a dentist can only do that if they know. One who does can look for early erosion before it turns into sensitivity.

Should you stop because of your teeth?

That is a decision for your prescriber, not this page. Most of the stomach side effects that drive the dental risk happen during dose increases and fade over time on every label,345 and a slower climb up the dose ladder is one of the things a prescriber can change. Dry mouth that started on the drug improved in the reported cases.10 Nobody has measured whether stopping protects teeth, because nobody has measured teeth at all.1

The appearance changes people often bundle with this, such as a hollower face after fast weight loss, are a different question; see Ozempic face. For the full side-effect lists, see Ozempic side effects and Zepbound side effects, and for managing the stomach symptoms themselves, the nausea, constipation and diarrhea guide. Legal claims over GLP-1 side effects are covered in the Ozempic lawsuit guide.

What it costs

Dental care is a separate bill; the medicine is the one we track. On our board today the cheapest cash GLP-1 program is $69 a month, compounded semaglutide starts at $69, and the middle of the board is $158. A licensed clinician decides whether you qualify, and compounded versions are not FDA approved.

For one molecule, see cheapest semaglutide and cheapest tirzepatide, both checked against the sellers' own pages.

Sources12
  1. Werner N, Pitchika V, Bumm CV, et al. GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps. J Dent Res, published online 14 October 2026 (PubMed abstract) read October 2026“While their metabolic and cardiovascular benefits are well established, the implications for oral health remain largely unexamined. Preclinical evidence consistently demonstrates anti-inflammatory and osteoprotective effects on periodontal and peri-implant tissues ... Conversely, several oral adverse effects have been reported based on pharmacovigilance analyses, including xerostomia, dysgeusia, and anosmia, particularly for semaglutide. Gastrointestinal side effects, particularly nausea (15% to 50%), vomiting (5% to 24%), and gastroesophageal reflux, pose a plausible but unquantified risk for tooth erosion and secondary caries. ... Despite this breadth of potential interactions, no prospective study has used any dental outcome as an endpoint in patients receiving GLP-1RAs.” ↩
  2. Gilligan G, Garola F, Wagner VP, Martins MD. Adverse Oral and Salivary Effects Associated With Glucagon-Like Peptide-1 Receptor Agonists: Clinical Insights. J Oral Pathol Med, published online 7 October 2026 (PubMed abstract) read October 2026“Reported manifestations include xerostomia, hyposalivation, dysgeusia, oral mucosal discomfort, burning sensations, and throat-related symptoms. Proposed mechanisms include modulation of cyclic adenosine monophosphate-dependent signaling in salivary acinar cells, altered autonomic regulation of salivary secretion, and dehydration secondary to gastrointestinal adverse events. Reduced salivary protection combined with gastric acid exposure from reflux or vomiting may increase susceptibility to dental erosion, although a direct association with these therapies has not been established. ... Evidence remains limited and largely indirect. CONCLUSION: Potential oral and salivary adverse effects warrant clinical awareness, careful medication history-taking, assessment of salivary function, and individualized preventive care.” ↩
  3. Ozempic (semaglutide injection) prescribing information and Medication Guide (DailyMed): gastrointestinal adverse reactions and dehydration read October 2026“In the pool of placebo-controlled trials, gastrointestinal adverse reactions occurred more frequently among patients receiving OZEMPIC than placebo (placebo 15.3%, OZEMPIC 0.5 mg 32.7%, OZEMPIC 1 mg 36.4%). The majority of reports of nausea, vomiting, and/or diarrhea occurred during dose escalation. ... gastroesophageal reflux disease (0%, 1.9%, 1.5%) ... Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration.” ↩
  4. Wegovy (semaglutide) prescribing information (DailyMed): gastrointestinal adverse reactions in adult weight-reduction trials read October 2026“In clinical trials in adults for weight reduction, 73% of WEGOVY injection-treated patients and 47% of patients receiving placebo reported gastrointestinal adverse reactions ... The most frequently reported reactions were nausea (44% vs. 16%), vomiting (25% vs. 6%), and diarrhea (30% vs. 16%). Other reactions that occurred at a higher incidence among WEGOVY injection-treated adult patients included dyspepsia, abdominal pain, abdominal distension, eructation, flatulence, gastroesophageal reflux disease, gastritis, hemorrhoids, and hiccups. These reactions were most frequently reported during dosage escalation.” ↩
  5. Zepbound (tirzepatide) prescribing information and Medication Guide (DailyMed): gastrointestinal adverse reactions and dry mouth read October 2026“In a pool of Study 1 and 2, gastrointestinal adverse reactions occurred more frequently among patients receiving ZEPBOUND (5 mg 56%, 10 mg 56%, 15 mg 56%) than placebo (30%). ... The majority of nausea, vomiting, and/or diarrhea events occurred during dose escalation and decreased over time. ... In a pool of Study 1 and 2, dry mouth or dry throat was reported by 1% of ZEPBOUND-treated patients and 0.1% of placebo-treated patients. ... Tell your healthcare provider if you have stomach problems that are severe or will not go away.” ↩
  6. American Dental Association, Oral Health Topics: Dental Erosion (causes) read October 2026“Erosive demineralization can result in progressive, irreversible loss of tooth mineral substance, and may be caused by intrinsic (e.g., acid reflux and excessive vomiting) and/or extrinsic (e.g., dietary) factors. ... Stomach acid may reach the oral cavity in cases of gastroesophageal reflux disease (GERD), a common condition in which gastric contents reflux back up into the esophagus and/or the mouth. ... Gastroesophageal reflux disease is considered a predisposing factor for dental erosion due to chronic regurgitation of gastric contents.” ↩
  7. American Dental Association, Oral Health Topics: Dental Erosion (what to do after vomiting and acid exposure) read October 2026“These patients should be cautioned against brushing their teeth immediately after vomiting. ... After vomiting, rinse the mouth with water, a sodium bicarbonate rinse, or milk. ... Saliva helps buffer and remove acids; chewing gum may help protect teeth from erosion by promoting salivary flow. (Sugar-free gum is specifically recommended to reduce the risk of cavities). ... Rinse with water rather than brushing teeth immediately after consuming acidic beverages. ... Brush teeth using a soft-bristle brush and fluoride toothpaste.” ↩
  8. American Dental Association, Oral Health Topics: Xerostomia (Dry Mouth) read October 2026“Reduced salivary flow can cause difficulties in tasting, chewing, swallowing, and speaking; it can also increase the chance of developing dental caries, demineralization of teeth, tooth sensitivity, and/or oral infections. ... Over-the-counter (OTC) and prescription medications that can contribute to or exacerbate oral dryness include: antihistamines (for allergy or asthma), antihypertensive medications, decongestants, pain medications, diuretics, muscle relaxants, glucagon-like peptide-1 (GLP-1) receptor agonists, and antidepressants.” ↩
  9. National Institute of Dental and Craniofacial Research (NIH), Dry Mouth read October 2026“Dry mouth also increases the risk for tooth decay or fungal infections in the mouth because saliva helps keep harmful germs in check. ... For example, if medication is causing dry mouth, the doctor or dentist may advise changing medications or adjusting the dosages, or may prescribe a saliva substitute. ... There are also self-care steps you can take to help ease dry mouth, such as drinking plenty of water, chewing sugarless gum, and avoiding tobacco and alcohol. ... Drinking plenty of water, 8 to 12 cups per day (64–96 ounces or 2-3 liters).” ↩
  10. Mawardi HH, Almazrooa SA, Dakhil SA, et al. Semaglutide-associated hyposalivation: A report of case series. Medicine (Baltimore) 2023;102(52):e36730 (PubMed abstract) read October 2026“We are reporting 3 cases for patients who were using semaglutide and developed secondary xerostomia. ... The patients' management varied between discontinuation of the drug, the use of pilocarpine, and conservative symptomatic management. OUTCOMES: The patients resumed acceptable salivary flow. LESSONS: We are reporting for the first time hyposalivation associated with the use of semaglutide. Further prospective, larger studies are warranted to confirm these findings.” ↩
  11. Khan FI, Vazquez SG, Mehdi Z, et al. Otolaryngologic Side Effects of GLP-1 Receptor Agonists. Laryngoscope 2025;135(7):2291-2298, an analysis of FDA adverse event reports (PubMed abstract) read October 2026“This was followed by GERD which also had very high signal ratios and was significant in all drugs assessed. Semaglutide also had significant signals in anosmia, dry mouth, dysgeusia, and Bell's palsy.” ↩
  12. Tu CY, Chen HL, Wu YH, Wu MJ. Association of tirzepatide versus GLP-1 receptor agonists with oral and periodontal outcomes in patients with type 2 diabetes: a global propensity score-matched cohort study. Diabetes Res Clin Pract 2026;242:113573 (PubMed abstract) read October 2026“After matching, each cohort included 97,993 patients. Tirzepatide was associated with lower risks of mortality (HR 0.69, 95% CI 0.59-0.80), periodontitis (0.70, 0.57-0.86), tooth extraction (0.89, 0.84-0.94), peri-implant complications (0.61, 0.52-0.70), periodontal procedures (0.89, 0.85-0.94), and oral or maxillofacial infections (0.70, 0.62-0.79). ... Given the low recorded event rates and limitations of retrospective EHR data, these associations require confirmation in prospective studies with systematic dental assessments.” ↩

Common questions

Does Ozempic damage your teeth?

Not directly, as far as anyone has shown. No GLP-1 label lists tooth damage, and an October 2026 Journal of Dental Research review says no prospective study has used a dental outcome as an endpoint. The risk dentists describe is indirect: vomiting and reflux put stomach acid on enamel, and dry mouth removes saliva's protection against decay. The review calls that risk plausible but unquantified.

Can Ozempic or Mounjaro cause dry mouth?

It is reported. Zepbound's label, which shares Mounjaro's molecule, lists dry mouth or dry throat in 1% of patients vs 0.1% on placebo. For semaglutide, a 2023 case series described 3 patients with low saliva, and FDA adverse event reports show a significant signal. The ADA now lists GLP-1 receptor agonists among medicines that can contribute to oral dryness.

Should I brush my teeth right after vomiting on a GLP-1?

The ADA advises against brushing immediately after vomiting. It says to rinse with water, a sodium bicarbonate (baking soda) rinse or milk instead, and to brush with a soft-bristle brush and fluoride toothpaste. That advice is for acid exposure in general; there is no GLP-1-specific dental guidance yet.

How common are dental problems on semaglutide or tirzepatide?

Nobody knows, because no study has measured teeth in people starting these drugs. What is measured is the stomach side effects: on Wegovy, 25% of trial participants reported vomiting vs 6% on placebo, and reflux disease was more common than on placebo. Most of it happened while the dose was being raised.

Are GLP-1s bad for your gums?

The early evidence leans the other way. An October 2026 dental review says preclinical studies consistently show anti-inflammatory and bone-protective effects on gum tissue, and a 2026 health-record study recorded less periodontitis and fewer tooth extractions on tirzepatide than on other GLP-1s. Neither is a prospective trial in people starting the drug.

How much does a GLP-1 cost?

On our board today the cheapest cash program is $69 a month, compounded semaglutide starts at $69, and the middle of the board is $158. A licensed clinician has to prescribe it, and compounded versions are not FDA approved.

When you are ready to look at costs, our list of online GLP-1 programs and the Ozempic price page both show prices with the date we last checked them.

Read next